Literature DB >> 10912311

Management of breast pain.

O Faiz1, I S Fentiman.   

Abstract

Mastalgia is a common problem among premenopausal women, and those with severe and protracted symptoms merit treatment. A range of non-hormonal and hormonal agents is available for symptom control among mastalgia sufferers but many are ineffective. Tamoxifen is the most effective and least toxic agent available for the treatment of severe chronic breast pain. Dosage with tamoxifen must be tailored to individual patient requirement and symptom control balanced against troublesome side-effects.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10912311

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN： 1368-5031            Impact factor:   2.503


  4 in total

1.  Open-Label Three Arm Trial Comparing Ormeloxifene, Gamma Linolenic Acid With Methylcobalamine + Vitamin C and Placebo in Mastalgia.

Authors:  Amrendra Verma; Deepti Bala Sharma; Sanjay Kumar Yadav; Dhananjaya Sharma
Journal:  Eur J Breast Health       Date:  2022-07-01

2.  A Randomized Pilot Study of Inositol in Association with Betaine and Boswellia in the Management of Mastalgia and Benign Breast Lump in Premenopausal Women.

Authors:  Vittorio Pasta; Simona Dinicola; Alessandro Giuliani; Abdel Halim Harrath; Saleh H Alwasel; Francesco Tartaglia; Alessandra Cucina; Mariano Bizzarri
Journal:  Breast Cancer (Auckl)       Date:  2016-04-20

3.  Existence of Cervical Discopathy in Non-Cyclic Mastodynia.

Authors:  Mustafa Alimoğulları; Hakan Buluş
Journal:  Breast Care (Basel)       Date:  2019-07-19       Impact factor: 2.860

4.  Clinical effectiveness of vitamin E and vitamin B6 for improving pain severity in cyclic mastalgia.

Authors:  Fatemeh Shobeiri; Khodayar Oshvandi; Mansour Nazari
Journal:  Iran J Nurs Midwifery Res       Date:  2015 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.